132414-06-3

Basic information

• Product Name: 4-(acetylamino)-2,6-dimethylbenzenesulfonyl chloride
• Synonyms: 4-(acetylamino)-2,6-dimethylbenzenesulfonyl chloride
• CAS NO: 132414-06-3
• Molecular Formula: C₁₀H₁₂ClNO₃S
• Molecular Weight: 261.72518
• Mol File: 132414-06-3.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(acetylamino)-2,6-dimethylbenzenesulfonyl chloride(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(acetylamino)-2,6-dimethylbenzenesulfonyl chloride(132414-06-3)
• EPA Substance Registry System: 4-(acetylamino)-2,6-dimethylbenzenesulfonyl chloride(132414-06-3)

Safety Data

• Hazardous Substances Data: 132414-06-3(Hazardous Substances Data)

Upstream product

• 2050-45-5 N-acetyl-3,5-dimethylaniline 
• 108-69-0 3,5-dimethylaminoaniline 

Downstream Products

• 64835-50-3 3.5-dimethyl-4-sulfonic acid 
• 67214-70-4 N-(3,5-dimethyl-4-sulfamoylphenyl)-acetamide 
• 132414-07-4 (4-acetamido-2,6-dimethylphenyl)sulfinic acid 
• 67214-72-6 3,5-Dimethyl-4-sulfamoyl-benzenesulfonyl chloride 
• 67214-71-5 4-amino-2,6-dimethylbenzenesulfonamide 
• 132414-03-0 (4-acetamido-2,6-dimethylphenylsulphonyl)nitromethane 

Relevant articles and documents

SUBSTITUTED 2-ANILINOPYRIMIDINES AS CELL CYCLE KINASE INHIBITORS OR RECEPTOR TYROSINE KINASE INHIBITORS, PRODUCTION OF SAID SUBSTANCES AND USE OF THE LATTER AS MEDICAMENTS

The invention relates to pyrimidine derivatives of general formula (I), in which R1, R2, R3, R4, A and D are defined as cited in the description, said derivatives being used as inhibitors of cyclin-dependent kin

AMIDOBENZENE DERIVATIVES, COMPOSITIONS AND USE

The invention concerns novel phenoxy- and phenylthio-acetyl derivatives of (4-amino-2,6-dimethyl-phenylsulphonyl)nitromethane and pharmaceutically acceptable salts thereof which are inhibitors of the enzyme aldose reductase and are of value, for example,

AMIDE DERIVATIVES, COMPOSITIONS AND USE

The invention concerns novel (oxamido- and ureido-phenylsulfonyl)nitromethane derivatives and pharmaceutically acceptable salts thereof which are inhibitors of the enzyme aldose reductase and are of value, for example, in the treatment of certain peripher